Funded by the Bill and Melinda Gates Foundation, CoVIC Seeks to Find Therapeutic Candidates for COVID-19 in Just Weeks SALT LAKE CITY, UTAH and LA JOLLA, CALIFORNIA (March 31, 2020) – Carterra Inc., the world leader in high-throughput antibody screening and characterization tools, and La Jolla Institute for Immunology (LJI), announced today that they will […]
As researchers from the broad scientific community in China are able to resume their research, Novogene, the global genome sequencing service provider, has announced that it will be scaling up its provision of sequencing services using Oxford Nanopore’s high throughput device, PromethION. Oxford Nanopore and Novogene will collaborate to expand the types of application available […]
– Developed in collaboration with Janssen, the Single Cell resource is being made available on the nferX® platform for free to academic researchers worldwide – – Announcement follows nference joining the COVID-19 Healthcare Coalition, a private sector collaborative with Mayo Clinic, MIT Faculty and Health IT leaders, coordinated by MITRE – nference today announced the launch of a first-in-class software […]
Company to pursue co-development collaborations for diverse clinical, pharmaceutical and biological research applications 1CellBio Inc. announced today an early access program for new droplet-based targeted cell selection and sequencing capabilities. This new approach integrates with the current inDrop workflow for a diverse range of clinical, pharmaceutical and biological research applications. The same targeted cell selection […]
BILLERICA, Mass — Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the following statement amid the continued COVID-19 global crisis, severely impacting public health and the economy. As COVID-19 continues to affect a growing number of people in the U.S. and around the world, Quanterix remains committed to the safety […]
Lausanne, Switzerland, and Boston, United States: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering the benefits of this solution to […]
In collaboration with Vanderbilt University Medical Center, La Jolla Institute for Immunology and Emory University, viral neutralization workflows on the Berkeley Lights platform are under accelerated development in response to the Coronavirus outbreak EMERYVILLE, Calif., March 26, 2020 /PRNewswire/ — Today Berkeley Lights, Inc., announced the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) with founding members Dr. James Crowe and […]
SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]
SHANGHAI, China,– Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the first vaccine candidate against the novel coronavirus […]
Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 – Proteona Pte. Ltd. and partners […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
